Publication | Closed Access

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

ThrombosisEndpoint Assessment TrialCardiovascular DiseaseCardiovascular PharmacologyPharmacotherapyAcute Myocardial InfarctionAtrial FibrillationPublic HealthMedicineAnticoagulantCardiologyEmergency MedicineAnesthesiologyMyocardial Infarction